Quick Takeaways
- David Scadden has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $875,256.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David Scadden
- Location
- Cambridge, MA
- Summary
- The estimated net worth of David Scadden is at least $875,256 dollars as of 14 Nov 2025. David Scadden is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $875.3K.
- Signature
- /s/ William Cook, as Attorney-in-fact for David Scadden
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Scadden and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: AGIOS PHARMACEUTICALS, INC. ($875,256).
- Past-year value change for that position: -$88,968.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of David Scadden
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Director | $875,256 | -$88,968 | -9.2% | 12 Nov 2025 |
| CARM | Carisma Therapeutics Inc. | Director | 01 Jul 2024 | |||
| EDIT | Editas Medicine, Inc. | Director | 06 Jun 2025 | |||
| DNTH | Magenta Therapeutics, Inc. | Director | 28 Jun 2022 |
Insider Transactions Reported by David Scadden:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.